The analysis showed that CLU was upregulated in a variety of tumours, including lymphoid neoplasm diffuse large B-cell lymphoma (DLBC), glioblastoma multiforme (GBM), kidney renal papillary cell carcinoma (KIRP), acute myeloid leukaemia (AML), brain lower grade glioma (LGG), ovarian serous cystadenocarcinoma (OV), thyroid carcinoma (THCA), and thymoma (THYM) (Figure 7(a)). This evidence concerns the gene CLU and glioblastoma.